July 15, 2009 Printable Version Newsletter Archive
LEGISLATIVE
  • House Democrats Release Reform Bill
  • REGULATORY
  • CMS Releases Proposed 2010 Physician Payment Rule
  • CMS Releases Readmission Rates for AMI, HF
  • FDA Approves Prasugrel
  • QUALITY
  • Register for ACC’s 2009 Legislative Conference
  • LEGISLATIVE

    House Democrats Release Reform Bill
    The House Democrats on Tuesday released a health care reform bill called "America’s Affordable Health Choices Act of 2009." It includes positive first steps toward physician payment reform by revising the flawed sustainable growth rate formula. It would eliminate the debt accumulated since 2000 to permanently change the SGR by allowing services to grow. To improve quality, it would continue funding for the Physician Quality Reporting Initiative (PQRI) through 2012, and provide an appeals process and faster feedback on reports.

    The bill also would require all Americans to purchase health insurance or be fined, although those with incomes of less than $88,000 annually would be eligible to receive a subsidy. In addition, the bill eliminates copayments and deductibles for preventative care; make it illegal to deny coverage for pre-existing conditions; creates a public health insurance plan; and promotes testing accountable care organizations. House Speaker Nancy Pelosi (D-Calif.) said that the House plans to vote on the bill before lawmakers break for August recess. For more information, and to comment, visit: lewinreport.acc.org.

    REGULATORY

    CMS Releases Proposed 2010 Physician Payment Rule
    The Centers for Medicare and Medicaid Services (CMS) recently released its 2010 proposed Medicare physician payment rule, which would slash payments for cardiovascular-related services. CMS projects that the proposed changes would reduce total Medicare payments to cardiology by 11 percent. In addition, CMS proposes a 21.5 percent reduction in the Medicare conversion factor due to the flawed SGR formula. In short, practices could face cuts ranging from 20 – 40 percent. For more on the rule, click here.

    The ACC is launching a comprehensive campaign to fight these cuts. You can get involved in several ways. First and foremost, all ACC members should contact their lawmakers through the ACC’s toll-free grassroots hotline (800-210-7193) and online action center (www.acc.org/can) and ask them to stop the cuts. Members can also take part in a video campaign that can be shared with members of Congress, regulatory officials and the public. Upload a 30 – 40 second video about the impacts of large-scale cuts on your ability to provide patients with the right care at the right time. You can post your video on YouTube or e-mail Molly Nichelson at mnichels@acc.org to have it posted for you. Don’t own a video camera? Submit your story via the ACC’s online forum, The Lewin Report. For questions, contact advocacydiv@acc.org.

    CMS Releases 30-Day Readmission Data for AMI, HF
    The Centers for Medicare and Medicaid Services (CMS) last week updated its Hospital Compare Web site with Medicare's 30-day hospital readmission rates for acute myocardial infarction (AMI), heart failure (HF) and pneumonia. In addition to readmission rates, the Hospital Compare Web site also provides information on 30-day mortality measures for AMI, HF and pneumonia. The ACC supports public reporting of these measures because they are intended to drive quality improvement efforts to enhance care in these important and high volume clinical areas.

    In an ongoing effort to raise awareness of the measures, the ACC is not only encouraging its members to review and act on the data, but is also gearing up to help hospitals respond to the measures through its new "Hospital to Home" (H2H) initiative, which will provide evidence-based strategies for reducing cardiovascular readmissions by 20 percent by 2012. Learn more or enroll at: http://www.acc.org/h2h/enrollment. For media coverage, visit The Lewin Report.

    FDA Approves Prasugrel
    The Food and Drug Administration has approved the blood-thinning drug prasugrel, marketed by Eli Lilly and Daiichi Sankyo Ltd. As Effient, to reduce the risk of blood clots from forming in patients who undergo angioplasty. The drug’s labeling will include a boxed warning alerting physicians that the drug can cause significant, sometimes fatal, bleeding. The drug should not be used in patients with active pathological bleeding, a history of transient ischemic attacks or stroke, or urgent need for surgery, including coronary artery bypass graft surgery. For more information, view a segment on CVN.

    QUALITY

    Register for ACC’s 2009 Legislative Conference
    The ACC will hold its 2009 Legislative Conference Sept. 13 – 15 at the Fairmont Hotel in Washington, D.C. Given the drastic payment cuts proposed by CMS, as well as efforts to pass overarching health reform legislation, don’t miss this opportunity to help educate Congress about the important work the ACC is doing in the areas of quality improvement and medical imaging. Even more importantly, you can help advocate for fair reimbursement and sound, unobtrusive policies that will ensure that cardiovascular professionals can continue to practice medicine in a manner that provides the greatest benefit for their patients. Click here to register now!

    -

     

    ADVERTISEMENT








    Back to Top | | Copyright © 2008 American College of Cardiology
    ACCInTouch Facebook Twitter LinkedIn
    Heart House | 2400 N Street, NW | Washington, DC 20037